Hyperlipoproteinemia Type 5 Latest Advances

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.

Journal: Journal of atherosclerosis and thrombosis

Published: June 17, 2026

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate.

Journal: Endocrinology, diabetes & metabolism case reports

Published: June 19, 2025

Coronary atherosclerotic plaque composition and classification in hypercholesterolemic pigs.

Journal: Atherosclerosis

Published: June 06, 2025

DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome.

Journal: Clinical biochemistry

Published: April 29, 2025

A Step Forward for Long-Acting PCSK9 Inhibition: Improvements Without a Breakthrough.

Journal: Journal of the American College of Cardiology

Published: September 16, 2024

Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.

Journal: Atherosclerosis

Published: March 14, 2024

Carotid intima-medial thickness in patients with severe hypertriglyceridemia.

Journal: Atherosclerosis plus

Published: February 07, 2024

Sonographic "Comet Tail" Artifacts in the Urinary Bladder in a Case of Type V Hyperlipidemia: A Previously Unreported Association.

Journal: Journal of medical ultrasound

Published: July 08, 2023

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment.

Journal: Cureus

Published: July 05, 2023

Acute Pancreatitis (AP) in Pregnancy and Its Complications From an Anesthesia Perspective: A Case Report.

Journal: Cureus

Published: May 11, 2023

Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.

Journal: BMC endocrine disorders

Published: March 21, 2023

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia.

Journal: Journal of personalized medicine

Published: November 22, 2022

Hyperlipoproteinemia Type 5 Latest Advances

Find the Latest Research About Hyperlipoproteinemia Type 5

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.

A Case of Familial Chylomicronemia Syndrome Caused by a Novel Homozygous GPIHBP1 Mutation Successfully Treated with the Selective PPARα Modulator Pemafibrate.

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate.

Reversibly reduced lipoprotein lipase in APOA5 c.553G>T-related hypertriglyceridemia successfully treated with pemafibrate.

Coronary atherosclerotic plaque composition and classification in hypercholesterolemic pigs.

Coronary atherosclerotic plaque composition and classification in hypercholesterolemic pigs.

DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome.

DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome.

A Step Forward for Long-Acting PCSK9 Inhibition: Improvements Without a Breakthrough.

A Step Forward for Long-Acting PCSK9 Inhibition: Improvements Without a Breakthrough.

Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.

Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome.

Carotid intima-medial thickness in patients with severe hypertriglyceridemia.

Carotid intima-medial thickness in patients with severe hypertriglyceridemia.

Sonographic "Comet Tail" Artifacts in the Urinary Bladder in a Case of Type V Hyperlipidemia: A Previously Unreported Association.

Sonographic "Comet Tail" Artifacts in the Urinary Bladder in a Case of Type V Hyperlipidemia: A Previously Unreported Association.

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment.

A Case of Type V Hyperlipoproteinemia Resistant to Insulin Treatment.

Acute Pancreatitis (AP) in Pregnancy and Its Complications From an Anesthesia Perspective: A Case Report.

Acute Pancreatitis (AP) in Pregnancy and Its Complications From an Anesthesia Perspective: A Case Report.

Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.

Dyslipidemia and hyperuricemia: a cross-sectional study of residents in Wuhu, China.

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia.

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia.